$CRI Cashflow Statement | Understand Stock

$CRI

$31.41 -$0.40 (1.26%) Close

$CRI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Jan 3, 2026	FY2024 12 months to Dec 28, 2024	FY2023 12 months to Dec 30, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Jan 1, 2022
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation of property, plant, and equipment
Amortization of intangible assets
Provisions for (recoveries of) excess and obsolete inventory, net
Goodwill impairment
Intangible asset impairment
Gain on partial termination of corporate lease
Loss on disposal of property, plant and equipment
Amortization of debt issuance costs
Stock-based compensation expense
Unrealized foreign currency exchange (gain) loss, net
Provisions for doubtful accounts receivable from customers
Loss on extinguishment of debt
Unrealized gain on investments
Pension plan settlement
Deferred income tax benefit
Other
Effect of changes in operating assets and liabilities:
Accounts receivable
Finished goods inventories
Prepaid expenses and other assets
Accounts payable and other liabilities

Net cash provided by operating activities
Cash flows from investing activities:
Capital expenditures
Proceeds from sale of investments
Disposals and recoveries from property, plant, and equipment
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from senior notes due 2025
Proceeds from senior notes due 2027
Proceeds from senior notes due 2031
Payment of senior notes due 2027
Premiums paid to extinguish debt
Payments of debt issuance costs
Borrowings under secured revolving credit facility
Payments on secured revolving credit facility
Repurchases of common stock
Dividends paid
Withholdings from vesting of restricted stock
Proceeds from exercise of stock options
Other
Net cash provided by (used in) financing activities

Net effect of exchange rate changes on cash and cash equivalents
Net increase in cash and cash equivalents
Cash and cash equivalents, beginning of fiscal year
Cash and cash equivalents, end of fiscal year

Comments